Borden KL - Search Results

1

Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities.

Strudwick S, Borden KL. Strudwick S, et al. Among authors: borden kl. Leukemia. 2002 Oct;16(10):1906-17. doi: 10.1038/sj.leu.2402724. Leukemia. 2002. PMID: 12357342 Review.

2

Structure/function in neuroprotection and apoptosis.

Borden KL. Borden KL. Ann Neurol. 1998 Sep;44(3 Suppl 1):S65-71. doi: 10.1002/ana.410440711. Ann Neurol. 1998. PMID: 9749576 Review.

3

UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML.

Seker H, Rubbi C, Linke SP, Bowman ED, Garfield S, Hansen L, Borden KL, Milner J, Harris CC. Seker H, et al. Among authors: borden kl. Oncogene. 2003 Mar 20;22(11):1620-8. doi: 10.1038/sj.onc.1206140. Oncogene. 2003. PMID: 12642865

4

Cell biology. Puzzled by PML.

Culjkovic-Kraljacic B, Borden KL. Culjkovic-Kraljacic B, et al. Among authors: borden kl. Science. 2010 Nov 26;330(6008):1183-4. doi: 10.1126/science.1199405. Science. 2010. PMID: 21109655 No abstract available.

5

¹H, ¹³C and ¹⁵N chemical shift assignments of the C-terminal domain of human UDP-Glucuronosyltransferase 2B7 (UGT2B7-C).

Osborne MJ, Rahardjo AK, Volpon L, Borden KLB. Osborne MJ, et al. Biomol NMR Assign. 2021 Oct;15(2):323-328. doi: 10.1007/s12104-021-10024-9. Epub 2021 Apr 18. Biomol NMR Assign. 2021. PMID: 33870481 Free PMC article.

6

TIF-90 tips the balance in rRNA synthesis.

Borden KL. Borden KL. Blood. 2014 Jul 24;124(4):467-8. doi: 10.1182/blood-2014-06-578914. Blood. 2014. PMID: 25061163 Free PMC article.

7

Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.

Clozel T, Yang S, Elstrom RL, Tam W, Martin P, Kormaksson M, Banerjee S, Vasanthakumar A, Culjkovic B, Scott DW, Wyman S, Leser M, Shaknovich R, Chadburn A, Tabbo F, Godley LA, Gascoyne RD, Borden KL, Inghirami G, Leonard JP, Melnick A, Cerchietti L. Clozel T, et al. Among authors: borden kl. Cancer Discov. 2013 Sep;3(9):1002-19. doi: 10.1158/2159-8290.CD-13-0117. Epub 2013 Aug 16. Cancer Discov. 2013. PMID: 23955273 Free PMC article. Clinical Trial.

8

The eukaryotic translation initiation factor eIF4E wears a "cap" for many occasions.

Borden KL. Borden KL. Translation (Austin). 2016 Aug 10;4(2):e1220899. doi: 10.1080/21690731.2016.1220899. eCollection 2016. Translation (Austin). 2016. PMID: 28090419 Free PMC article.

9

Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Culjkovic B, Borden KL. Culjkovic B, et al. Among authors: borden kl. J Oncol. 2009;2009:981679. doi: 10.1155/2009/981679. Epub 2009 Dec 13. J Oncol. 2009. PMID: 20049173 Free PMC article.

10

MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL.

Landon AL, Muniandy PA, Shetty AC, Lehrmann E, Volpon L, Houng S, Zhang Y, Dai B, Peroutka R, Mazan-Mamczarz K, Steinhardt J, Mahurkar A, Becker KG, Borden KL, Gartenhaus RB. Landon AL, et al. Among authors: borden kl. Nat Commun. 2014 Nov 18;5:5413. doi: 10.1038/ncomms6413. Nat Commun. 2014. PMID: 25403230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page